A carregar...
Cardiovascular Complications Associated with Novel Angiogenesis Inhibitors: Emerging Evidence and Evolving Perspectives
Novel cancer therapies targeting tumor angiogenesis have revolutionized treatment options in a variety of tumors. Specifically, VEGF signaling pathway (VSP) inhibitors have been introduced into clinical practice at a rapid pace over the last decade. It is becoming increasingly clear that VSP inhibit...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3621011/ https://ncbi.nlm.nih.gov/pubmed/23290365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tcm.2012.09.008 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|